MAPT and Alzheimer disease: Altogether, we provide evidence that genetic regulation of MAPT expression across different brain cell-types has a stronger impact on AD risk in APOE*4− versus APOE*4+ subjects but surprisingly reveal a protective role for increased MAPT expression.